Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients

NCT05068726 · clinicaltrials.gov ↗

TERMINATED

Status

51

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor discretion (low recruitment rate)

Conditions

Metastatic Breast Cancer

Interventions

DRUG: 18F Fluoroestradiol Radiopharmaceutical with PET/CT

Sponsor

GE Healthcare

Collaborators

[object Object]
[object Object]
[object Object]